Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Opioids Market, by Application
1.4.2 Europe Opioids Market, by Product Type
1.4.3 Europe Opioids Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Opioids Market by Application
3.1 Europe Pain Management Market by Country
3.2 Europe Cough Treatment Market by Country
3.3 Europe Diarrhea Treatment Market by Country
Chapter 4. Europe Opioids Market by Product Type
4.1 Europe Methadone Market by Country
4.2 Europe Oxycodone Market by Country
4.3 Europe Hydrocodone Market by Country
4.4 Europe Fentanyl Market by Country
4.5 Europe Codeine Market by Country
4.6 Europe Morphine Market by Country
4.7 Europe Other Product Type Market by Country
Chapter 5. Europe Opioids Market by Country
5.1 Germany Opioids Market
5.1.1 Germany Opioids Market by Application
5.1.2 Germany Opioids Market by Product Type
5.2 UK Opioids Market
5.2.1 UK Opioids Market by Application
5.2.2 UK Opioids Market by Product Type
5.3 France Opioids Market
5.3.1 France Opioids Market by Application
5.3.2 France Opioids Market by Product Type
5.4 Russia Opioids Market
5.4.1 Russia Opioids Market by Application
5.4.2 Russia Opioids Market by Product Type
5.5 Spain Opioids Market
5.5.1 Spain Opioids Market by Application
5.5.2 Spain Opioids Market by Product Type
5.6 Italy Opioids Market
5.6.1 Italy Opioids Market by Application
5.6.2 Italy Opioids Market by Product Type
5.7 Rest of Europe Opioids Market
5.7.1 Rest of Europe Opioids Market by Application
5.7.2 Rest of Europe Opioids Market by Product Type
Chapter 6. Company Profiles
6.1 Johnson and Johnson
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.2 AstraZeneca PLC
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.3 Boehringer Ingelheim International Gmbh
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional & Segmental Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Approvals and Trials:
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expenses
6.5 Mallinckrodt PLC
6.5.1 Company Overview
6.5.1 Financial Analysis
6.5.2 Segmental and Regional Analysis
6.5.3 Research & Development Expense
6.6 Sanofi S.A.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Acquisition and Mergers:
6.7 Pfizer, Inc.
6.7.1 Company Overview
6.7.1 Financial Analysis
6.7.2 Regional Analysis
6.7.3 Research & Development Expense
6.7.4 Recent strategies and developments:
6.7.4.1 Approvals and Trials:
6.8 Teva Pharmaceutical Industries Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expenses
6.8.5 Recent strategies and developments:
6.8.5.1 Product Launches and Product Expansions:
6.8.5.2 Approvals and Trials:
6.9 Sun Pharmaceutical Industries Ltd.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Purdue Pharma L.P.
6.10.1 Company Overview
Unique Offerings 